UFIS-SWE-IG
0.1.0 - ci-build

UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions

Example Bundle: TramadolRetardHexal100mgdepot-SE-PLC-MPD-BBDL

Tramadol Retard Hexal 100 mg depottablett

MPID: SE-100000848-00021235
EURDID: 3002

Full name: Tramadol Retard Hexal 100 mg depottablett

- Scientific name part: Tramadol Retard Hexal

- Strength part: 100 mg

- Pharmaceutical dose form part: depottablett

Name usage: Swedish (Kingdom of Sweden)

Authorised dose form: Prolonged-release tablet

Legal status of supply: Medicinal product subject to medical prescription

Domain: Human use

Resource status: Current

Product classification:

  • 100000097261 tramadol

Marketing Authorisation 1 of 1

Authorisation number: 21235

Region: Kingdom of Sweden

Marketing authorisation holder: Sandoz A/S

Identifier:

  • LOC-100001468

Status: Valid (2005-04-29)

Package 1 of 1

PCID:

Description:
Blister, 100 tabletter

Marketing status:

  • Kingdom of Sweden: Marketed

Pack size:

  • 100 Tablet

Package: 1 Box (Cardboard)

Containing:

Package: 10 Blister (Aluminium) (PolyPropylene)

Containing: 10 Tablet

Manufactured Item

Dose form: Prolonged-release tablet

Unit of presentation: Tablet

Ingredient

Role: Active

Substance: Tramadol hydrochloride

Presentation strength: 100 milligram(s) / 1 Tablet

Reference strength:
Tramadol 87.95 milligram(s) / 1 Tablet

Administrable Product (1 of 1)

Dose form: Prolonged-release tablet

Unit of presentation:

Route of administration:

  • Oral use

Ingredients:

Ingredient

Role: Active

Substance: Tramadol hydrochloride

Presentation strength: 100 milligram(s) / 1 Tablet

Reference strength:
Tramadol 87.95 milligram(s) / 1 Tablet